标题
The treatment gap: The missed opportunities for osteoporosis therapy
作者
关键词
Osteoporosis, Bisphosphonates, Treatment gap
出版物
BONE
Volume 144, Issue -, Pages 115833
出版商
Elsevier BV
发表日期
2020-12-23
DOI
10.1016/j.bone.2020.115833
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Fracture Risk During and After Bisphosphonate Drug Holidays
- (2020) Annette L. Adams MEDICAL CARE
- Zoledronate
- (2020) Ian R. Reid et al. BONE
- History of alendronate
- (2020) Steven R. Cummings et al. BONE
- Bisphosphonates and lifespan
- (2020) Jacqueline R. Center et al. BONE
- Assessment of Cardiovascular Safety of Anti-Osteoporosis Drugs
- (2020) N. R. Fuggle et al. DRUGS
- Molecular mechanisms of action of bisphosphonates and new insights into their effects outside the skeleton
- (2020) Michael J. Rogers et al. BONE
- On the pharmacological evaluation of bisphosphonates in humans
- (2020) Serge Cremers et al. BONE
- Atypical Femur Fracture Risk versus Fragility Fracture Prevention with Bisphosphonates
- (2020) Dennis M. Black et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fracture risk following intermission of osteoporosis therapy
- (2019) E.M. Dennison et al. OSTEOPOROSIS INTERNATIONAL
- Deep neural networks for automatic detection of osteoporotic vertebral fractures on CT scans
- (2018) Naofumi Tomita et al. COMPUTERS IN BIOLOGY AND MEDICINE
- Management of Patients With High Baseline Hip Fracture Risk by FRAX Reduces Hip Fractures-A Post Hoc Analysis of the SCOOP Study
- (2018) Eugene McCloskey et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The Cost-Effectiveness of Screening in the Community to Reduce Osteoporotic Fractures in Older Women in the UK: Economic Evaluation of the SCOOP Study
- (2018) David A Turner et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Screening in the community to reduce fractures in older women (SCOOP): a randomised controlled trial
- (2018) Lee Shepstone et al. LANCET
- European guidance for the diagnosis and management of osteoporosis in postmenopausal women
- (2018) J.A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- Hip fracture risk and safety with alendronate treatment in the oldest-old
- (2017) K. F. Axelsson et al. JOURNAL OF INTERNAL MEDICINE
- Effectiveness of a two-step population-based osteoporosis screening program using FRAX: the randomized Risk-stratified Osteoporosis Strategy Evaluation (ROSE) study
- (2017) K. H. Rubin et al. OSTEOPOROSIS INTERNATIONAL
- Mind the (treatment) gap: a global perspective on current and future strategies for prevention of fragility fractures
- (2017) N. C. W. Harvey et al. OSTEOPOROSIS INTERNATIONAL
- Anti-Osteoporosis Medication Prescriptions and Incidence of Subsequent Fracture Among Primary Hip Fracture Patients in England and Wales: An Interrupted Time-Series Analysis
- (2016) Samuel Hawley et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Secular trends in fracture incidence in the UK between 1990 and 2012
- (2016) R. Y. van der Velde et al. OSTEOPOROSIS INTERNATIONAL
- Secondary prevention of fractures after hip fracture: a qualitative study of effective service delivery
- (2016) S. Drew et al. OSTEOPOROSIS INTERNATIONAL
- Intravenous zoledronate for osteoporosis: less might be more
- (2016) Andrew Grey Therapeutic Advances in Musculoskeletal Disease
- The Effect of 6 versus 9 Years of Zoledronic Acid Treatment in Osteoporosis: A Randomized Second Extension to the HORIZON-Pivotal Fracture Trial (PFT)
- (2015) Dennis M. Black et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Epidemiology and postoperative outcomes of atypical femoral fractures in older adults: A systematic review
- (2015) Kareeann S. F. Khow et al. Journal of Nutrition Health & Aging
- Effective secondary fracture prevention: implementation of a global benchmarking of clinical quality using the IOF Capture the Fracture® Best Practice Framework tool
- (2015) M. K. Javaid et al. OSTEOPOROSIS INTERNATIONAL
- Using self-reports of pain and other variables to distinguish between older women with back pain due to vertebral fractures and those with back pain due to degenerative changes
- (2015) E. M. Clark et al. OSTEOPOROSIS INTERNATIONAL
- Efficacy and Safety of Single-Dose Zoledronic Acid for Osteoporosis in Frail Elderly Women
- (2015) Susan L. Greenspan et al. JAMA Internal Medicine
- Clinician’s Guide to Prevention and Treatment of Osteoporosis
- (2014) F. Cosman et al. OSTEOPOROSIS INTERNATIONAL
- Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Second Report of a Task Force of the American Society for Bone and Mineral Research
- (2013) Elizabeth Shane et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Comparative gastrointestinal safety of bisphosphonates in primary osteoporosis: a network meta-analysis
- (2013) M. Tadrous et al. OSTEOPOROSIS INTERNATIONAL
- Capture the Fracture: a Best Practice Framework and global campaign to break the fragility fracture cycle
- (2013) K. Åkesson et al. OSTEOPOROSIS INTERNATIONAL
- Long-term fracture rates seen with continued ibandronate treatment: pooled analysis of DIVA and MOBILE long-term extension studies
- (2013) P. D. Miller et al. OSTEOPOROSIS INTERNATIONAL
- Osteoporosis in the European Union: medical management, epidemiology and economic burden
- (2013) E. Hernlund et al. Archives of Osteoporosis
- Best Practices in Secondary Fracture Prevention: Fracture Liaison Services
- (2013) Paul J. Mitchell Current Osteoporosis Reports
- Making the first fracture the last fracture: ASBMR task force report on secondary fracture prevention
- (2012) John A Eisman et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Incidence of atypical nontraumatic diaphyseal fractures of the femur
- (2012) Richard M Dell et al. JOURNAL OF BONE AND MINERAL RESEARCH
- A pragmatic randomised controlled trial of the effectiveness and cost-effectiveness of screening older women for the prevention of fractures: rationale, design and methods for the SCOOP study
- (2012) L. Shepstone et al. OSTEOPOROSIS INTERNATIONAL
- Treatment of postmenopausal osteoporosis with delayed-release risedronate 35 mg weekly for 2 years
- (2012) M. R. McClung et al. OSTEOPOROSIS INTERNATIONAL
- An appendix to the 2012 IOF–ECTS guidelines for the management of glucocorticoid-induced osteoporosis
- (2012) S. Lekamwasam et al. Archives of Osteoporosis
- The relationship between the chemistry and biological activity of the bisphosphonates
- (2011) Frank H. Ebetino et al. BONE
- Bisphosphonates: The first 40years
- (2011) R. Graham G. Russell BONE
- Adverse Reactions and Drug–Drug Interactions in the Management of Women with Postmenopausal Osteoporosis
- (2011) René Rizzoli et al. CALCIFIED TISSUE INTERNATIONAL
- Atrial fibrillation and bisphosphonate therapy
- (2011) Michael Pazianas et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Randomized controlled trial of a primary care-based screening program to identify older women with prevalent osteoporotic vertebral fractures: Cohort for skeletal health in Bristol and Avon (COSHIBA)
- (2011) Emma M Clark et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Esophageal and gastric cancer incidence and mortality in alendronate users
- (2011) Bo Abrahamsen et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The effect of 3 versus 6 years of Zoledronic acid treatment of osteoporosis: A randomized extension to the HORIZON-Pivotal Fracture Trial (PFT)
- (2011) Dennis M Black et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Bisphosphonate Use and Atypical Fractures of the Femoral Shaft
- (2011) Jörg Schilcher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of monthly oral ibandronate is sustained over 5 years: the MOBILE long-term extension study
- (2011) P. D. Miller et al. OSTEOPOROSIS INTERNATIONAL
- Long-term administration of quarterly IV ibandronate is effective and well tolerated in postmenopausal osteoporosis: 5-year data from the DIVA study long-term extension
- (2011) G. Bianchi et al. OSTEOPOROSIS INTERNATIONAL
- Prevalence of Osteonecrosis of the Jaw in Patients With Oral Bisphosphonate Exposure
- (2009) Joan C. Lo et al. JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started